Newer Drug Extends Lives of Young Breast Cancer Patients
SATURDAY, June 1, 2019 (HealthDay News) — Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found. The drug, called Kisqali (ribociclib), is already approved for treating such patients — based on earlier results showing it canContinue Reading